The exclusive interview for SPINOFF.COM with Shay Herchcovici, Head of Business Development at Betalin Therapeutics Ltd. on their technology of micro pancreas to fight diabetes.
Betalin Therapeutics a biotech company developing the Engineered Micro Pancreas (EMP) to treat diabetes. This breakthrough technology will enable to implant pancreatic cells, which include insulin-producing cells to restore the body's intrinsic insulin generation capabilities. Micro-pancreas technology of implanting pancreatic cells includes insulin-producing cells (i.e. beta cells) that restore the body's intrinsic insulin generation capabilities in order to provide an effective treatment for diabetes. The procedure involves injecting millions of islets (the pancreatic cell clusters that “house” the insulin-producing beta cells) harvested from cadavers, followed by immunosuppression therapy. The engineered bio-pancreas can be implanted virtually anywhere in the body. With such technology, the diabetes sufferers around the globe will be able to set themselves free of the daily treatments.